feed,title,long_url,short_url
gNews,EXAS Stock Eyes Buy Point After Cancer Diagnostic Test Proves Its Merit - Investor's Business Daily,https://www.investors.com/research/ibd-stock-of-the-day/exas-stock-eyes-buy-point-cancer-diagnostic-test-proves-merit/,https://j.mp/37u5L3a
